NLRC5	B:C2932687
promotes	O
cell	O
proliferation	I:C0596290
via	O
regulating	O
the	O
AKT	O
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
in	O
hepatocellular	O
carcinoma	I:C2239176
.	O

NLRC5	O
promotes	O
cell	B:C0596290
proliferation	I:C0596290
via	O
regulating	O
the	O
AKT	O
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
in	O
hepatocellular	O
carcinoma	I:C2239176
.	O

NLRC5	O
promotes	O
cell	O
proliferation	I:C0596290
via	O
regulating	O
the	O
AKT	B:C1515844
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
in	O
hepatocellular	O
carcinoma	I:C2239176
.	O

NLRC5	O
promotes	O
cell	O
proliferation	I:C0596290
via	O
regulating	O
the	O
AKT	O
/	O
VEGF	B:C3271788
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
in	O
hepatocellular	O
carcinoma	I:C2239176
.	O

NLRC5	O
promotes	O
cell	O
proliferation	I:C0596290
via	O
regulating	O
the	O
AKT	O
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
in	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
.	O

NLRC5	B:C2932687
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	O
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	O
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	O
to	O
regulate	O
immune	O
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	O
carcinoma	I:C2239176
(	O
hepatocellular	O
carcinoma	I:C2239176
)	O
.	O

NLRC5	O
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	B:C4277661
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	O
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	O
to	O
regulate	O
immune	O
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	O
carcinoma	I:C2239176
(	O
hepatocellular	O
carcinoma	I:C2239176
)	O
.	O

NLRC5	O
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	O
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	B:C1148916
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	O
to	O
regulate	O
immune	O
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	O
carcinoma	I:C2239176
(	O
hepatocellular	O
carcinoma	I:C2239176
)	O
.	O

NLRC5	O
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	O
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	O
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	B:C0684224
to	O
regulate	O
immune	O
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	O
carcinoma	I:C2239176
(	O
hepatocellular	O
carcinoma	I:C2239176
)	O
.	O

NLRC5	O
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	O
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	O
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	O
to	O
regulate	O
immune	B:C0301872
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	O
carcinoma	I:C2239176
(	O
hepatocellular	O
carcinoma	I:C2239176
)	O
.	O

NLRC5	O
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	O
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	O
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	O
to	O
regulate	O
immune	O
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
(	O
hepatocellular	O
carcinoma	I:C2239176
)	O
.	O

NLRC5	O
,	O
a	O
newly	O
found	O
member	O
of	O
the	O
NLR	O
family	I:C4277661
and	O
the	O
largest	O
member	O
of	O
nucleotide	O
-	I:C1148916
binding	I:C1148916
,	O
has	O
been	O
reported	O
to	O
regulate	O
immune	O
responses	I:C0301872
and	O
is	O
associated	O
with	O
hepatocellular	O
carcinoma	I:C2239176
(	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
)	O
.	O

We	O
investigated	O
the	O
mechanisms	O
and	O
signaling	B:C0037080
pathways	I:C0037080
of	O
NLRC5	O
in	O
hepatocellular	O
carcinoma	I:C2239176
progression	O
.	O

We	O
investigated	O
the	O
mechanisms	O
and	O
signaling	O
pathways	I:C0037080
of	O
NLRC5	B:C2932687
in	O
hepatocellular	O
carcinoma	I:C2239176
progression	O
.	O

We	O
investigated	O
the	O
mechanisms	O
and	O
signaling	O
pathways	I:C0037080
of	O
NLRC5	O
in	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
progression	O
.	O

We	O
investigated	O
the	O
mechanisms	O
and	O
signaling	O
pathways	I:C0037080
of	O
NLRC5	O
in	O
hepatocellular	O
carcinoma	I:C2239176
progression	B:C0178874
.	O

Increased	O
expression	B:C1171362
of	O
NLRC5	O
,	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	O
hepatocellular	O
carcinoma	I:C2239176
tissue	O
.	O

Increased	O
expression	O
of	O
NLRC5	B:C2932687
,	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	O
hepatocellular	O
carcinoma	I:C2239176
tissue	O
.	O

Increased	O
expression	O
of	O
NLRC5	O
,	O
vascular	B:C0078058
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	O
hepatocellular	O
carcinoma	I:C2239176
tissue	O
.	O

Increased	O
expression	O
of	O
NLRC5	O
,	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	B:C0078058
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	O
hepatocellular	O
carcinoma	I:C2239176
tissue	O
.	O

Increased	O
expression	O
of	O
NLRC5	O
,	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	B:C0086418
hepatocellular	O
carcinoma	I:C2239176
tissue	O
.	O

Increased	O
expression	O
of	O
NLRC5	O
,	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
tissue	O
.	O

Increased	O
expression	O
of	O
NLRC5	O
,	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
(	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
)	O
were	O
found	O
in	O
human	O
hepatocellular	O
carcinoma	I:C2239176
tissue	B:C0040300
.	O

There	O
was	O
a	O
positive	B:C1446409
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	B:C2932687
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	B:C0078058
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	B:C1171362
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	B:C0596290
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	B:C2932687
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	B:C1514559
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	B:C2717940
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	B:C0007634
with	O
NLRC5	O
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	B:C2932687
silencing	O
treatment	O
.	O

There	O
was	O
a	O
positive	O
correlation	O
between	O
NLRC5	O
and	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
cell	O
proliferation	I:C0596290
were	O
enhanced	O
in	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
,	O
but	O
inhibited	O
in	O
cells	O
with	O
NLRC5	O
silencing	B:C0598496
treatment	O
.	O

Interestingly	O
,	O
we	O
found	O
that	O
up	B:C0041904
-	I:C0041904
regulation	I:C0041904
of	O
NLRC5	O
also	O
coordinated	O
the	O
activation	O
of	O
PI3K	O
/	O
AKT	O
signaling	O
pathway	O
.	O

Interestingly	O
,	O
we	O
found	O
that	O
up	O
-	I:C0041904
regulation	I:C0041904
of	O
NLRC5	B:C2932687
also	O
coordinated	O
the	O
activation	O
of	O
PI3K	O
/	O
AKT	O
signaling	O
pathway	O
.	O

An	O
AKT	B:C0251991
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	B:C0078058
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	B:C1171362
and	O
AKT	O
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	B:C0164786
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	B:C1158886
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	O
in	O
HepG2	B:C2717940
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	B:C2932687
-	O
overexpressing	O
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	B:C1514559
HepG2	O
cells	I:C2717940
.	O

An	O
AKT	O
inhibitor	I:C0251991
LY294002	I:C0251991
blocked	O
vascular	O
endothelial	I:C0078058
growth	I:C0078058
factor	I:C0078058
-	I:C0078058
A	I:C0078058
expression	O
and	O
AKT	O
phosphorylation	O
in	O
HepG2	O
cells	I:C2717940
and	O
NLRC5	O
-	O
overexpressing	O
HepG2	B:C2717940
cells	I:C2717940
.	O

These	O
results	O
demonstrate	O
that	O
NLRC5	B:C2932687
promotes	O
hepatocellular	O
carcinoma	I:C2239176
progression	O
via	O
the	O
AKT	O
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
.	O

These	O
results	O
demonstrate	O
that	O
NLRC5	O
promotes	O
hepatocellular	B:C2239176
carcinoma	I:C2239176
progression	O
via	O
the	O
AKT	O
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
.	O

These	O
results	O
demonstrate	O
that	O
NLRC5	O
promotes	O
hepatocellular	O
carcinoma	I:C2239176
progression	B:C0178874
via	O
the	O
AKT	O
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
.	O

These	O
results	O
demonstrate	O
that	O
NLRC5	O
promotes	O
hepatocellular	O
carcinoma	I:C2239176
progression	O
via	O
the	O
AKT	B:C1515844
/	O
VEGF	O
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
.	O

These	O
results	O
demonstrate	O
that	O
NLRC5	O
promotes	O
hepatocellular	O
carcinoma	I:C2239176
progression	O
via	O
the	O
AKT	O
/	O
VEGF	B:C3271788
-	I:C3271788
A	I:C3271788
signaling	I:C3271788
pathway	I:C3271788
.	O

